Results 151 to 160 of about 7,312 (203)

Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use. [PDF]

Subst Use Addctn J
Leyde SE, Merrill JO, Treadway AJ, Pike KC, Price CJ.   +4 more
europepmc   +1 more source

A self-assessment of opioid use disorder services at a Pacific Northwest County jail. [PDF]

Subst Abuse Treat Prev Policy
Schumacher JE, Bell SA, Ahsan A, Cochran PR, Gutierrez AG, Morris ER, Cain BJ.   +6 more
europepmc   +1 more source

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review. [PDF]

Addiction
Roberts E, Kalk N, Strang J.
europepmc   +1 more source

Iatrogenic withdrawal syndrome in adult intensive care unit: a scoping review. [PDF]

Front Med (Lausanne)
Moisa E, Tuculeanu G, Corneci D, Negoita SI, Bilotta F.   +4 more
europepmc   +1 more source

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial.

JAMA Intern Med
Winhusen TJ, Lofwall MR, Kropp F, Lewis D, Smid MC, Young JL, Hodgkins C, Krans EE, Hansen Z, Wachman EM, Schiff DM, Guille C, Rudolf V, Chowdhury T, Leeman L, Lewis M, Matthews AG, Cochran G, King J, Wilder C, Rosa C.   +20 more
europepmc   +1 more source

Short-Acting Opioid Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder.

JAMA Netw Open
Logan A, Baisey T, McCulloch CE, Bazazi AR, Martin M, Suen LW.   +5 more
europepmc   +1 more source

Pharmacists’ Role in the Continued Care of Patients under Opiate Substitution Treatment [PDF]

Therapie, 2013
In France, over 170 000 persons benefit from opiate substitution treatment. The treatment delivery is most often assured by community pharmacies spread out throughout the territory. The aim of this study is to better know the continued care of individuals treated by methadone or high-dose buprenorphine in community pharmacies in Lille (North of France).
Nassir Messaadi, Olivier Cottencin
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

In Control?: Ukrainian Opiate Substitution Treatment Patients Strive for a Voice in Their Treatment

Substance Use and Misuse, 2012
This article explores the burgeoning advocacy movement for methadone and buprenorphine treatment by patients, parents, and doctors in Ukraine, and their efforts to remake a system that infantilizes and controls patients into one where patients have a voice in their treatment.
Maria, Golovanevskaya, Leonid, Vlasenko, Roxanne, Saucier   +2 more
exaly   +3 more sources

Economic evaluation: A comparison of methadone versus buprenorphine for opiate substitution treatment [PDF]

Drug and Alcohol Dependence, 2013
The cost of opiate substitution is usually considered lower in cost when methadone is used, as compared to that of buprenorphine, however the overall cost effectiveness of substitution programmes comparing the two drugs remains largely unknown.We evaluated the treatment cost and effectiveness of methadone and buprenorphine when used in an opiate ...
Maas, Jim, Barton, Garry, Maskrey, Vivienne, Pinto, Hayley, Holland, Richard   +4 more
openaire   +4 more sources

Regaining control: The patient experience of supervised compared with unsupervised consumption in opiate substitution treatment [PDF]

Drug and Alcohol Review, 2013
AbstractIntroduction and AimsSupervised consumption of opiate substitution treatment is standard practice in the UK yet little is known about the patient experience of this treatment modality. This study aimed to assess the patient experience of receiving supervised compared with unsupervised consumption of methadone or buprenorphine.Design and ...
Notley, Caitlin, Holland, Richard, Maskrey, Vivienne, Nagar, Jessica, Kouimtsidis, Christos   +4 more
openaire   +4 more sources